Manufacturer record

Micron Pharmaceuticals: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

8 batches manufactured by Micron Pharmaceuticals (Gujarat) were declared Not of Standard Quality between January 2019 and May 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

8 records linked to Micron Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
8Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jan 2019 to May 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

8
NSQ batches since 2019
7
Products affected
Assay
Most common failure
May 2026
Latest alert

Flagged batches per year

2019 · 32020 · 12025 · 32026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Lorazepam Tablets I.P. 2 mg T240628Mfg 2024-06 · Exp 2027-05 Dissolution.Dissolution RDTL ErnakulamState lab May 2026
Naltrexone HCL Tablets IP 50 mg T2507109Mfg 2025-07 · Exp 2027-06 Brittle TabletsOther Food & Drugs Laboratory, VadodaraState lab Nov 2025
Naltrexone HCL Tablets IP 50 mg T250651Mfg 2025-06 · Exp 2027-05 Brittle TabletsOther Food & Drugs Laboratory, VadodaraState lab Nov 2025
Acetazolamide Tablets IP 250 mg T 240840Mfg 2024-08 · Exp 2027-07 It fails the test ?Dissolution? Specified in the laboratory protocol as per IPDissolution DTL ThiruvananthapuramState lab Feb 2025
Ampicillin Capsules I.P. 250 mg CB181217Mfg 2018-12 · Exp 2020-11 AssayAssay CDTL MumbaiCDSCO lab Jan 2020
Calcium Carbonate Tablets I.P. T190324Mfg 2019-03 · Exp 2021-02 Uniformity of WeightUniformity of weight/content CDTL MumbaiCDSCO lab Sep 2019
Alumina, Magnesium Hydroxide, Magnesium Carbonate and Simethicone Tablets (MILUCID TABLETS) T170638Mfg 2017-06 · Exp 2019-05 Assay of Activated DimethiconeAssay RDTL ChandigarhCDSCO lab Mar 2019
Ramipril Tablets I.P. 2.5 mg T180301Mfg 2018-03 · Exp 2020-02 AssayAssay CDTL MumbaiCDSCO lab Jan 2019

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.